Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
The Biologics Manufacturing Centre (BMC) is seeking a Quality Control Coordinator - Data Review in Montréal to ensure accuracy and integrity of analytical data in GMP-compliant workflows.
You'll review data, support GDP and ALCOA+ practices, and help issue internal Certificates of Analysis while assisting analysts on GMP requirements. Proficiency in French and English is expected, with intermediate Excel skills.
QUALITY CONTROL Full Time OFFICE Montréal, QC, CA
The Biologics Manufacturing Center (BMC) Inc. is a new biomanufacturing facility created in response to the pandemic. A not-for-profit organization, the BMC aims to better meet the biopharmaceutical needs of Canadians. The BMC helps support projects of public interest, actively contributes to the overall growth and resilience of the Canadian life sciences industry and fosters industry development and innovation through Canadian production. Backed by a committed and innovative team of employees, the BMC fosters a culture of agility and transparency, with a collaborative, result-oriented approach.
We are looking for a Quality Control Coordinator - Data Review who will contribute to the quality of analytical data by ensuring its accuracy, integrity and compliance. Working closely with Analysts, the person will review analytical data and associated documentation, support the application of Good Manufacturing Practices (GMP) and contribute to the issuance of internal Certificates of Analysis.
The Quality Control Coordinator - Data Review will have the following responsibilities:
The BMC is a new facility in the heart of Montreal, completed in June 2021. It supports the growth of the country's biologics production capacity, ensuring that vaccines and other related products can be manufactured safely, right here at home. Thanks to its state-of-the-art facilities and the knowledge of its team, the BMC can produce biopharmaceutical products such as viral vector, protein subunit and virus-like particle vaccines, as well as other biological products. It is a key player in Canada's ability to respond rapidly to future national and global health emergencies.